The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,724 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 6,828 | 702,500 | SH | SOLE | 702,500 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 14,083 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 10,614 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| ATHERSYS INC NEW | COM | 04744L106 | 858 | 1,416,400 | SH | Put | SOLE | 1,416,400 | 0 | 0 | |
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 2,167 | 175,000 | SH | Call | SOLE | 175,000 | 0 | 0 | |
| BEAM THERAPEUTICS INC | COM | 07373V105 | 1,719 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 4,128 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 127 | 1,988 | SH | SOLE | 1,988 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 4,680 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 4,380 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | ||
| CALITHERA BIOSCIENCES INC | COM | 13089P101 | 404 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 4,258 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CELULARITY INC | COM CL A | 151190105 | 697 | 80,000 | SH | Put | SOLE | 80,000 | 0 | 0 | |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 586 | 65,282 | SH | SOLE | 65,282 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 2,451 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 13,827 | 845,155 | SH | SOLE | 845,155 | 0 | 0 | ||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 1,687 | 777,610 | SH | SOLE | 777,610 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 3,452 | 55,000 | SH | Call | SOLE | 55,000 | 0 | 0 | |
| CURIS INC | COM NEW | 231269200 | 833 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,220 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,957 | 1,272,244 | SH | SOLE | 1,272,244 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 11,760 | 174,500 | SH | SOLE | 174,500 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,425 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 2,973 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 3,156 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| HYPERFINE INC | COM CL A | 44916K106 | 270 | 76,162 | SH | SOLE | 76,162 | 0 | 0 | ||
| IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 328 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
| INARI MED INC | COM | 45332Y109 | 19,941 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 951 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 14,860 | 924,147 | SH | SOLE | 924,147 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 6,361 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 2,212 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
| LIANBIO | SPONSORED ADS | 53000N108 | 1,206 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 7,359 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,934 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 14 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 18,696 | 465,654 | SH | SOLE | 465,654 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 7,753 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 5,963 | 171,592 | SH | SOLE | 171,592 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 2,426 | 559,019 | SH | SOLE | 559,019 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 6,608 | 317,400 | SH | Call | SOLE | 317,400 | 0 | 0 | |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 7,104 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 5,113 | 215,900 | SH | Put | SOLE | 215,900 | 0 | 0 | |
| RELAY THERAPEUTICS INC | COM | 75943R102 | 2,245 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| RENOVACOR INC | COM | 75989E106 | 846 | 199,490 | SH | SOLE | 199,490 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 26 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 6,677 | 468,905 | SH | SOLE | 468,905 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 4,758 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SCIENCE 37 HOLDINGS INC | COM | 808644108 | 1,184 | 221,382 | SH | SOLE | 221,382 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 338,730 | 750,000 | SH | Put | SOLE | 750,000 | 0 | 0 | |
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 13,941 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 9,030 | 160,000 | SH | Put | SOLE | 160,000 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 11,495 | 11,000,000 | PRN | SOLE | 11,000,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 2,577 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 5,496 | 1,374,098 | SH | SOLE | 1,374,098 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 925 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,446 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 9,574 | 207,500 | SH | SOLE | 207,500 | 0 | 0 | ||